Log In
BCIQ
Print this Print this
 

S-Graft

  Manage Alerts
Collapse Summary General Information
Company VBI Vaccines Inc.
DescriptionRecombinant human DNase I (rhDNase I)
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPreclinical
Standard IndicationGraft-versus-host disease (GvHD)
Indication DetailsTreat acute graft-versus-host disease (GvHD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today